Labshake search
Citations for R&D Systems :
651 - 700 of 3824 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2021Quote: ... or human ACE-2 Fc (chimera, R&D Systems) in serial dilutions of 500-31.3 ng/ml PBS-T were incubated (n = 6 ...
-
bioRxiv - Immunology 2022Quote: ... mouse anti-Dectin-2 antibody (R&D Systems, MAB1525) was preincubated with the Dectin-2-Fc fusion protein at a concentration of 50 mg/ml for 30 minutes prior to adding the mixture to FLPs.
-
bioRxiv - Immunology 2022Quote: ... goat anti-ACE-2 (R&D systems, #AF933, 1;1000), rabbit anti-STING (Cell Signaling ...
-
bioRxiv - Immunology 2022Quote: Recombinant Human IL-2 was from R&D systems. Dual-Luciferase Report Assay System was purchased from Promega ...
-
bioRxiv - Neuroscience 2019Quote: ... 2 µM tetrodotoxin citrate (TTX, R&D Systems 1078) or 25 mM glutamate (Sigma G1251 ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... dilution series of native relaxin-2 (R&D Systems), were added to the cells and luminescence measurements were taken 30 minutes after relaxin-2 addition ...
-
bioRxiv - Physiology 2022Quote: ... Dectin-2 (1:100, clone 17611; R&D Systems), TLR2 (1:200 ...
-
bioRxiv - Developmental Biology 2023Quote: ... and IGF-2 (#292-G2-250, R&D systems). Additionally ...
-
bioRxiv - Cell Biology 2023Quote: ... 2% Noggin/R-Spondin–conditioned media (R&D Systems), 100 ng/mL recombinant human Wnt3A (R&D Systems) ...
-
bioRxiv - Cell Biology 2024Quote: ... and IGF-2 (#292-G2-250, R&D systems). Additionally ...
-
bioRxiv - Cell Biology 2019Quote: ... C2C12 and cardiac fibroblasts were serum starved for 24 h before adding medium containing 5 ng/ml recombinant TGFβ1 for 2 days (R&D Systems, Minneapolis ...
-
bioRxiv - Microbiology 2021Quote: ... serum was incubated for 2 h with polyclonal sheep IgG anti-LL-37 (2.5 – 20 μg ml−1; R&D Systems) or anti-hNP-1 (2.5 – 20 μg ml−1 ...
-
bioRxiv - Immunology 2020Quote: ... 2 × 105 cells/ well in a 24 well plate were seeded on 10ug/ml fibronectin-coated cover slips (R&D systems) in 500ul 20ng/ml macrophage colony stimulating factor (MCSF ...
-
bioRxiv - Immunology 2021Quote: ... In another experiment mice were treated intravenously 2 days post infection with 12.5 μg/kg recombinant murine IL-23 (1887-ML-010/CF, R&D Systems) for 3 consecutive days.
-
bioRxiv - Cell Biology 2021Quote: Isolated cardiac fibroblasts at Passage (P)2 were treated with 10 ng/mL TGF-β1 (R&D Systems Cat #240-B) in Fibroblast Growth Medium 3 for four days to assess myofibroblast differentiation ...
-
bioRxiv - Bioengineering 2022Quote: ... Flow cells were washed and incubated with mouse anti-human VE-cadherin (2 μg/ml clone 123413, R&D Systems, US) followed by goat anti-mouse lgG AF® 594 (1:500 ...
-
bioRxiv - Cell Biology 2020Quote: ... Fibers were incubated in plating medium consisting of 15% Fetal Bovine Serum (Hyclone) and 2 ng/ml bFGF (R&D Systems) in DMEM.
-
bioRxiv - Neuroscience 2022Quote: ... Group 2 ligands were derived from human transcriptomic data and included: TGFβ2 (R&D Systems, Cat. 302-B2-002, 5ng/mL), NLGN1 (Sino Biological ...
-
bioRxiv - Cancer Biology 2020Quote: ... Dot blots were washed three times with PBST and incubated with 15 μl of DAB (3,3’-Diaminobenzidine) chromogen (2 ml of DAB chromogen (860001, R&D Systems) diluted in DAB chromogen buffer (860005 ...
-
bioRxiv - Developmental Biology 2023Quote: ... media was changed daily with hindgut medium (RPMI 1640, 1X GlutaMAX, 2% defined FBS, 2µM CHIR99021 and 500ng/ml FGF4 (R&D Systems) until day 8 ...
-
bioRxiv - Cell Biology 2023Quote: ... SH-SY5Y cells were pre-treated for 16 h with Type I Interferon (1000 Units/mL; R&D Systems, 11200-2) and treated with HMW Poly(I:C ...
-
bioRxiv - Immunology 2023Quote: ... cells were pelleted by centrifugation and media was replaced with plasmablast generation media: 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-6 (Peprotech) ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Bioengineering 2021Quote: ... and 3 U/mL EPO (R&D Systems 287-TC). Cells were cultured for 7 days followed EHT and assessed using by flow cytometry.
-
bioRxiv - Immunology 2019Quote: ... IFNα (3×104 units/ml, R&D Systems, Minneapolis, MN), (3 ...
-
bioRxiv - Immunology 2023Quote: ... 30 ng/ml IL-3 (R&D Systems, 203-IL), 30 ng/ml TPO (PeproTech ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 days with 200 ng/mL FGF9 (R&D Systems), 1 μg/mL heparin (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 10 ng/ml rhIL-3 (#203-IL, R&D Systems) and 10 ng/ml rhIL-6 (#206-IL ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (0.97 ng/ml; R&D Systems, 203-IL), CXCL12 (97.39 ng/ml) ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (5.3 ng/ml; R&D Systems, 203-IL), CXCL12 (9.7 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/mL NT-3 (R&D Systems, 267-N3), 10 ng/mL EGF ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), and Doxycycline Hydrochloride (1ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), EdU (5-ethynyl-2’-deoxyuridine ...
-
bioRxiv - Cancer Biology 2022Quote: CAR and BOXR1030 T cells were activated with immobilized recombinant GPC3 protein (0.3 ug/mL) (R&D Systems, Cat# 2119-GP-050) over a 6-day time course ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems). The medium was changed every 2 days ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems), SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Developmental Biology 2021Quote: ... 50 ng/ml Bmp8a (R&D Systems, cat. 1073-BP-010), 2 ng/ml SCF (R&D Systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... and 50 ng/ml epidermal growth factor (EGF) (R&D Systems). Differentiation medium is CMGF(+ ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant human BMP4 (50 ng/ml; R&D Systems, Minneapolis, MN) or equivalent volume of 4mM HCl (solvent for BMP4 reconstitution ...
-
bioRxiv - Cell Biology 2021Quote: ... 50 ng/ml human SCF (255-SC-010, R&D Systems), 10 ng/ml human IL-3 (203-IL-010 ...
-
bioRxiv - Microbiology 2022Quote: ... + 50 ng/ml of glial-derived neurotrophic factor (R&D Systems) + 1 μg/ml of mitomycin C (MedChemExpress ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (50 units/mL; R&D Systems) and harvest for citrullination detection as described above.
-
bioRxiv - Biochemistry 2021Quote: ... and 50 ng/mL GM-CSF (215-GM, R&D systems) and seeded in 96-well plates (105/well ...
-
bioRxiv - Developmental Biology 2022Quote: ... 50 ng/ml activin A (R&D Systems, Inc., Minneapolis, MN), 3 μM CHIR99021 (Cayman Chemical ...
-
bioRxiv - Bioengineering 2021Quote: ... and brain derived neurotrophic factor (50 ng/ml, R&D Systems) to support neuronal survival (Hansen et al ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with Flt3 ligand (Flt3L; 50 ng/ml; R&D Systems) in the absence or presence of rosiglitazone (40 μM ...
-
bioRxiv - Immunology 2020Quote: ... and 50 ng/mL GM-CSF (215-GM; R&D Systems). KhES1 ESCs were kindly provided by Dr ...
-
bioRxiv - Immunology 2021Quote: ... IL-23 (50 ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...